Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $172 at BofA Securities

October 20, 2026 4:59 AM
BofA Securities analyst Tazeen Ahmad raised the price target on Gilead Sciences (NASDAQ: GILD) to $172.00 (from $168.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change